Photo

Photo detail

Laura Shawver, CEO of Synthorx, in the lab located in the incubator COI Pharmaceuticals. Synthorx recently raised $151 million through an initial public offering.

Stories this photo appears in:

BIOTECH: Expanding Genetic Alphabet Could Help in Cancer Fight

A drug approved in the 1990s boosts cancer-killing cells. But it can also wreak havoc on the immune system.

Tease photo